The historical rank and industry rank for BioNexus Gene Lab's FCF Margin % or its related term are showing as below:
BGLC'
s FCF Margin % Range Over the Past 10 Years
Min: -181.1 Med: -7.41 Max: 4.56
Current: -14.84
During the past 6 years, the highest FCF Margin % of BioNexus Gene Lab was 4.56%. The lowest was -181.10%. And the median was -7.41%.
BGLC's FCF Margin % is ranked worse than 80.89% of 1533
companies
in the Chemicals industry
Industry Median: 1.08
vs BGLC: -14.84
BioNexus Gene Lab FCF Margin % Historical Data
The historical data trend for BioNexus Gene Lab's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BioNexus Gene Lab's FCF Margin %
For the Specialty Chemicals subindustry, BioNexus Gene Lab's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioNexus Gene Lab's FCF Margin % Distribution in the Chemicals Industry
For the Chemicals industry and Basic Materials sector, BioNexus Gene Lab's FCF Margin % distribution charts can be found below:
* The bar in red indicates where BioNexus Gene Lab's FCF Margin % falls into.
BioNexus Gene Lab FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
BioNexus Gene Lab's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BioNexus Gene Lab FCF Margin % Related Terms
Thank you for viewing the detailed overview of BioNexus Gene Lab's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
BioNexus Gene Lab (BioNexus Gene Lab) Business Description
BioNexus Gene Lab Corp is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management. It focuses on developing and marketing safe, effective, and non-invasive blood tests for the early detection of diseases. The company's non-invasive blood tests analyze changes in ribonucleic acid (or RNA) to detect the potentiality of 11 different diseases. These diseases include eight cancers (nasopharyngeal, lung, liver, stomach, breast, cervical, prostate, and colon), two bowel diseases (colitis and Crohn), and osteoarthritis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BGLC has been successfully added to your 